Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Having -c- – wherein x is chalcogen – bonded directly to...
Reexamination Certificate
2006-09-12
2006-09-12
Richter, Johann (Department: 1626)
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Having -c-, wherein x is chalcogen, bonded directly to...
C546S081000
Reexamination Certificate
active
07105531
ABSTRACT:
This invention provides compounds of formula 1, having the structurewhich are useful as inhibitors of protein tyrosine kinase and are antiproliferative agents.
REFERENCES:
patent: 4139704 (1979-02-01), Borror et al.
patent: 4332952 (1982-06-01), Schnur
patent: 4952584 (1990-08-01), Thompson et al.
patent: 5480883 (1996-01-01), Spada et al.
patent: 5597832 (1997-01-01), Michaelides et al.
patent: 5679683 (1997-10-01), Bridges et al.
patent: 5955464 (1999-09-01), Barker
patent: 0755934 (1996-07-01), None
patent: 0837063 (1997-10-01), None
patent: 95/19970 (1995-07-01), None
patent: 96/09294 (1996-03-01), None
patent: 97/05137 (1997-02-01), None
patent: 97/13760 (1997-04-01), None
patent: 97/30044 (1997-08-01), None
patent: 97/49688 (1997-12-01), None
patent: 98/02434 (1998-01-01), None
patent: 98/13350 (1998-04-01), None
patent: 98/43960 (1998-10-01), None
Theodoridis et al., “Synthesis and Structure-Activity Relationships of 1-Aryl-4-substituted-1,4-dihydro-5H-tetrazol-5-ones, a Novel Class of Pre- and Post-emergence Herbicides,” Pestic. Sci. 30: 259-274 (1990).
Ross et al., “Inhibitors of Dopamine β-Hydroxylase. 3. Some 1-(Pyridylmethyl)imidazole-2-thiones,” J. Med. Chem. 30:1309-1313 (1987).
Denat et al., “Pyrrolyl Compounds of Main Group Elements. Synthesis of Group 14 5-Metallated Pyrrole-2-Carbaldehydes,” J. Organometallic Chem. 423:173-182 (1992).
Berger Dan M.
Boschelli Diane H.
DeMorin Frenel F.
Dutia Minu D.
Powell Dennis W.
Hogan Jr. John W.
Richter Johann
Rosenblum Anne M.
Sackey Ebenezer
WYETH
LandOfFree
Tricyclic protein kinase inhibitors does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Tricyclic protein kinase inhibitors, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Tricyclic protein kinase inhibitors will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-3583944